Close mobile menu×
Close mobile menu

Michael T. Yin, MD

Board Certifications: 
Infectious Disease
Accepting New Patients

Appointments

Phone Appointments

New and Existing Patients: 
(212) 305-8039

myColumbiaDoctors

For existing patients, login to make an appointment, view documentation or contact your care provider.

Credentials & Experience

Board Certifications

  • Infectious Disease

Clinical Expertise

  • HIV Infection
  • HIV Medicine
  • Infectious Disease
  • HIV/AIDS

Specialties

Education & Training

  • Columbia University College of Physicians and Surgeons
  • Residency: NewYork-Presbyterian Hospital/Columbia University Medical Center
  • Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center

About Michael Yin

Dr. Yin is an Associate Professor of Medicine in the Division of Infectious Diseases.

Academic Titles

  • Associate Professor of Medicine at CUMC

Administrative Positions

  • Associate Fellowship Program Director

Hospital Affiliations

  • NewYork-Presbyterian/Columbia

Gender

  • Male

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Affinity

  • Essential Plan
  • Medicaid Managed Care
  • Medicare Managed Care

Amida Care

  • Special Needs Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/GHI

  • HMO
  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • Blue Priority
  • EPO
  • HMO
  • Medicare (Mediblue)
  • NYP Employee Plan
  • Pathway (Exchange)
  • POS
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Medicare

  • Traditional Medicare (NY)

Multiplan

  • Multiplan

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

POMCO

  • POMCO

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • EPO
  • Essential Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Contact & Locations

1
180 Fort Washington Avenue
Suite 2-242
New York, New York 10032
Phone:
(212) 305-8039
Fax:
(212) 305-1754
Primary

Research

Dr. Yin's primary research focus is on the metabolic complications of HIV infection and antiretroviral therapy. He is the Principal Investigator of a NIAID-funded R01 to examine the effects of the menopausal transition on bone and muscle outcomes in HIV-infected women in the Women’s Interagency HIV study (WIHS), utilizing imaging and biomarker techniques, novelin vitrobone precursor cell assays and assessment of muscle mass, quality and functional performance. He is the Principal Investigator of a NIAID-funded R01 to examine the effects of the menopausal transition on bone and muscle outcomes in HIV-infected women in the Women’s Interagency HIV study (WIHS), utilizing imaging and biomarker techniques, novel in vitro bone precursor cell assays and assessment of muscle mass, quality and functional performance. He is the Co-Principal Investigator of a NICHD-funded R01 to examine bone health in perinatally HIV-infected children on antiretrovirals in South Africa. He is also an investigator in the AIDS Clinical Trials Group (ACTG), HIV Vaccine Trials Network (HVTN), and a member of Bone and Metabolic Working Groups for the WIHS, Veterans Aging Cohort Study (VACS), and ACTG

Research Interests

  • HIV therapy and metabolic complications

Grants

IMPACT OF COMBINED USE OF DEPOT MEDROXYPROGESTERONE ACETATE CONTRACEPTION AND TENOFOVIR PREEXPOSURE PROPHYLAXIS ON BONE HEALTH (DEPO-PREP) (Federal Gov)

May 17 2017 - Mar 31 2022

ORAL IMMUNE ACTIVATION AND ALVEOLAR BONE LOSS IN HIV-INFECTED POSTMENOPAUSAL WOMEN (Federal Gov)

Apr 1 2017 - Jan 31 2022

PRECISION IN SYMPTOM SELF-MANAGEMENT (PRISSM) CENTER (Federal Gov)

Aug 16 2016 - May 31 2021

COLUMBIA PARTNERSHIP FOR PREVENTION AND CONTROL OF HIV/AIDS CLINICAL TRIALS UNIT (COLUMBIA PARTNERSHIP CTU) (Federal Gov)

Dec 1 2013 - Nov 30 2020

OPTIMIZING CLINICAL USE OF POLYMYXIN B: TEACHING OLD DRUG TO TREAT SUPERBUGS (Federal Gov)

Apr 1 2017 - May 31 2020

A PHASE 3, MULTI-CENTER, RANDOMIZED, OPEN-LABEL STUDY OF CARBAVANCE (MEROPENEM/RPX7009) VERSUS BEST AVAILABLE THERAPY IN SUBJECTS WITH SELECTED SERIOUS INFECTIONS DUE TO CARBAPENEM-RESISTANT ENTEROBACTERIACEAE (P&S Industry Clinical Trial)

Oct 29 2014 - Oct 29 2019

A MULTI-CENTER, RETROSPECTIVE STUDY OF CASES OF SERIOUS INFECTIONS DUE TO CARBAPENEM-RESISTANT ENTEROBACTERIACEAE (P&S Industry Clinical Trial)

Jun 23 2014 - Jun 23 2019

BIOLOGICAL AGING IN OLDER HIV-INFECTED AFRICAN AMERICANS (Federal Gov)

Sep 1 2017 - May 31 2019

A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND STUDY TO COMPARE THE EFFICACY AND SAFETY OF CADAZOLID VERSUS VANCOMYCIN IN SUBJECTS WITH CLOSTRIDIUM DIFFICILE-ASSOCIATED DIARRHEA (CDAD) (P&S Industry Clinical Trial)

Apr 21 2014 - Apr 21 2019

A PHASE 3, RANDOMIZED, DOUBLE-BLIND STUDY TO EVALUATE THE SAFETY AND EFFICACY OF ELVITEGRAVIR/COBICISTAT/EMTRICITABINE/TENOFOVIR ALAFENAMIDE VERSUS ELVITEGRAVIR/COBICISTAT/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE IN HIV-1 POSITIVE, ADULTS (P&S Industry Clinical Trial)

Sep 3 2013 - Sep 3 2018

HIV AND THE MENOPAUSAL TRANSITION: EFFECTS ON MUSCULOSKELETAL HEALTH (Federal Gov)

May 1 2011 - Apr 30 2018

BONE AND RENAL OUTCOMES IN VIROLOGICALLY STABLE SOUTH AFRICAN HIV-INFECTED ADOLESCENTS SWITCHING TO TENOFOVIR (TDF)-CONTAINING ANTIRETROVIRAL THERAPY. (Private)

Dec 15 2016 - Dec 16 2017

BONE HEALTH IN PERINATALLY HIV-INFECTED SOUTH AFRICAN CHILDREN ON ANTIRETROVIRALS (Federal Gov)

Jul 16 2012 - Jun 30 2017

OSTEOPOROSIS IN HIV INFECTED POSTMENOPAUSAL WOMEN (Federal Gov)

Jul 1 2010 - Jun 30 2016

TAMIFLU-ROCHE: A MULTICENTER, STUDY OF THE SAFETY OF OSELTAMIVIR ADMINSTERED INTRAVENOUSLY FOR THE TREATMENT OF INFLUENZ (P&S Industry Clinical Trial)

Sep 30 2010 - Sep 30 2015

AGING AND FRACTURE RISK AMONG HIV-INFECTED AND HIV-UNINFECTED MEN (Federal Gov)

Sep 1 2011 - Aug 31 2015

GS-US-236-0103 (P&S Industry Clinical Trial)

Jul 14 2010 - Jul 14 2015

PHASE 3,OPEN-LABEL,SINGLE-ARM TRIAL TO EVALUATE THE SAFETY, TOLERABILITY & IMMUNOGENICITY OF 3 DOSES OF 13VPNC IN HIV (P&S Industry Clinical Trial)

Mar 10 2010 - Mar 10 2015

A QUALITATIVE STUDY OF HEPATITIS C VIRUS TREATMENT BARRIERS AMONG HCV/HIV CO-INFECTED PATIENTS AND THEIR PROVIDERS IN THE ERA OF TRANSITION TO INTERFERON-SPARING REGIMENS (Private)

Nov 26 2013 - Nov 25 2014

ACTG LEADERSHIP AND OPERATIONS CENTER SUPPLEMENTAL FUNDING (Federal Gov)

Jun 1 2012 - Dec 31 2013

ACTG LEADERSHIP AND OPERATIONS CENTER SUPPLEMENTAL FUNDING (Federal Gov)

Jun 1 2012 - Dec 31 2013

HVTN 505CORE LEADERSHIP ROLE (Federal Gov)

Jun 1 2009 - Dec 31 2013

HIV VACCINE TRIALS UNIT - HVTN 505 (Federal Gov)

Jun 1 2009 - Aug 31 2013

CO-CHAIR ACTG PROTOCOL A5280 (Federal Gov)

Jun 1 2012 - Aug 15 2013

SOLID ORGAN TRANSPLANTATION IN HIV-MULTI-SITE STUDY (Federal Gov)

Sep 26 2008 - Aug 31 2012

CO-CHAIR ACTG PROTOCOL A5280 (Federal Gov)

Jun 1 2011 - May 31 2012

MK-0518/RALTEGRAVIR (P&S Industry Clinical Trial)

Feb 25 2009 - Dec 31 2011

GS-US-183-0144, A MULTICENTER, RANDOMIZED, DOUBLE-BLIND,DOUBLE-DUMMY,PHASE 3 STUDY OF THE SAFETY AND EFFICACY OF RITONAV (P&S Industry Clinical Trial)

Mar 25 2009 - Jun 30 2011

Selected Publications

Arpadi S, Shiau S, Strehlau R, Pinillos F, Patel F, Kuhn L, Coovadia A, Ramteke S, Kaufman JL, Yin MT. Efavirenz is associated with higher bone mass in South African children with HIV. AIDS 2016 Jul 16 [Epub ahead of print] PMI: 27427876.

Sharma A, Hoover DR, Shi Q, Holman S, Plankey MW, Wheeler AL, Weber K, Floris-Moore M, Bolivar HH, Vance DE, Mack WJ, Golub ET, Holstad M, Yin MT. Falls among middle-aged women in the Women’s Interagency HIV Study. Antiviral Therapy 2016, Jul 18 [Epub ahead of print] PMID: 27427794.

Manavalan JS, Apradi S, Tharmarajah S, Shah J, Zhang CA, Foca M, Neu N, Bell DL, Nishiyama K, Kousteni S, Yin MT. Abnormal bone acquisition with early-life HIV infection: role of immune activation and senescent osteogenic precursors. Journal of Bone and Mineral Research 2016 Jun 10 (Epub ahead of print). PMID: 27283956

Yin MT, Skanderson M, Shiau S, Harwood KE, Ascheim J, Rimland D, Gibert C, Rodriguez-Barradas M, Bedimo R, Womack J. “Fracture prediction with modified FRAX in older HIV+ and HIV- men” Journal of Acquired Immune Deficiency Syndrome 2016 Mar 19 (Epub ahead of print) PMID: 27003493

Sharma A, Shi Q, Hoover DR, Anastos K, Tien PC, Young M, Cohen MH, Golub ET, Gustafson D, Yin MT. Increased fracture incidence in middle-aged HIV-infected and uninfected women: updated results from the Women’s Interagency HIV Study. Journal of Acquired Immunodeficieny Syndrome 2015, Sept 1;70(1):54-61. PMID 26322667

Overton ET, Chan ES, Brown TT, Tebas P, McComsey GA, Tenorio A, Melbourne K, Napoli A, Ribaudo HJ, Yin MT. High-dose vitamin D and calcium attenuates bone loss with antiretroviral therapy initiation: a prospective, randomized placebo-controlled trial for bone health in HIV-infected individuals. Annals of Internal Medicine 2015, 162(12):815-824. PMID: 26075752

Dong HV, Cortes YI, Shiau S, Yin MT. Osteoporosis and fractures in HIV/HCV-coinfection: a systemic review and meta-analysis, AIDS, 2014 28(14):2119-31. PMID: 24977441

Yin MT, Lund E, Shah J, Zhang CA, Foca M, Neu N, Nishiyama KK, Zhou B, Guo E, Nelson J, Bell D, Shane E, Arpadi SA. Lower peak bone mass and abnormal trabecular and cortical microarchitecture in young men infected with HIV early in life, AIDS 2013 28(3): 345-54. PMID: 24072196

Shiau S, Lund EC, Arpadi S, Yin MT, Incident fractures in HIV-infected individuals: a systematic review and meta-analysis, AIDS 2013; 27(12):1949-1957. PMID: 24126140

Yin MT, Kendall MA, Wu X, Tassiopoulos K, Hochberg M, Huang JS, Glesby MJ, Bolivar H, McComsey GA. Fractures after antiretroviral initiation: An analysis of the ACTG longitudinal linked randomized trial (ALLRT) study. AIDS 2012 26(17):2175-84. PMID: 22951635

Yin MT, Zhang CA, McMahon DJ, Ferris DC, Irani D, Colon I, Cermers S, Shane E. Higher rates of bone loss in postmenopausal HIV-infected women: A longitudinal study. Journal of Clinical Endocrinology and Metabolism 2012 97(2): 554-62. PMID 22090266